Perimenopause and Cognition

Obstetrics and Gynecology Clinics of North America

Volumn 38, Issue 3, 2011, Pages 519-535

  Greendale, Gail A ^a   Derby, Carol A ^b   Maki, Pauline M ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Cardiovascular risk factors; Cognitive function; Estrogen; Follicle stimulating hormone; Menopause; Ovariectomy; Perimenopause

Indexed keywords

CHOLESTEROL; CONJUGATED ESTROGEN; ESTRADIOL; FOLLITROPIN; HYDROCORTISONE; LUTEINIZING HORMONE;

ALZHEIMER DISEASE; ANXIETY DISORDER; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLIMACTERIUM; COGNITION; DEPRESSION; DIABETES MELLITUS; EXECUTIVE FUNCTION; HUMAN; MEMORY DISORDER; MENOPAUSAL SYNDROME; MENOPAUSE; MENTAL PERFORMANCE; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; NEUROIMAGING; NONHUMAN; OVARIECTOMY; OVARY INSUFFICIENCY; POSTMENOPAUSE; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; REVIEW; SEROTONINERGIC SYSTEM; SLEEP DISORDER; VASOMOTOR DISORDER; VERBAL MEMORY; WORKING MEMORY;

AGE FACTORS; ANIMALS; BRAIN; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; HUMANS; HYDROCORTISONE; MODELS, ANIMAL; OVARIECTOMY; PERIMENOPAUSE; PRIMARY OVARIAN INSUFFICIENCY;

EID: 80053254018     PISSN: 08898545     EISSN: 15580474     Source Type: Journal    
DOI: 10.1016/j.ogc.2011.05.007     Document Type: Review

References (106)

1. Mitchell E., Woods N. Midlife women's attributions about perceived memory changes: Observations from the Seattle Midlife Women's Health Study. J Womens Health Gend Based Med 2001, 10:351-362.
2. Gold E.B., Sternfeld B., Kelsey J.L., et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol 2000, 152:463-473.
3. McEwen B.S. Invited review: estrogens effects on the brain: Multiple sites and molecular mechanisms. J Appl Physiol 2001, 91:2785-2801.
4. McEwen B. Estrogen actions throughout the brain. Recent Prog Horm Res 2002, 57:357-384.
5. Gleason C.E., Cholerton B., Carlsson C.M., et al. Neuroprotective effects of female sex steroids in humans: current controversies and future directions. Cell Mol Life Sci 2005, 62:299-312.
6. Morrison J.H., Brinton R.D., Schmidt P.J., et al. Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women. J Neurosci 2006, 26:10332-10348.
7. Brann D.W., Dhandapani K., Wakade C., et al. Neutrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications. Steroids 2007, 72:381-405.
8. Hughes T.F., Ganguli M. Modifiable midlife risk factors for late-life cognitive impairment and dementia. Curr Psychiatry Rev 2009, 5:73-92.
9. Greendale G.A., Wight R.G., Huang M.H., et al. Menopause-associated symptoms and cognitive performance: results from the study of women's health across the nation. Am J Epidemiol 2010, 171:1214-1224.
10. Donner N., Handa R.J. Estrogen receptor beta regulates the expression of tryptophan-hydroxylase 2 mRNA within serotonergic neurons of the rat dorsal raphe nuclei. Neuroscience 2009, 163:705-718.
11. Weiser M.J., Wu T.J., Handa R.J. Estrogen receptor-beta agonist diarylpropionitrile: biological activities of R- and S-enantiomers on behavior and hormonal response to stress. Endocrinology 2009, 150:1817-1825.
12. Lund T.D., Rovis T., Chung W.C., et al. Novel actions of estrogen receptor-beta on anxiety-related behaviors. Endocrinology 2005, 146:797-807.
13. Amin Z., Gueorguieva R., Cappiello A., et al. Estradiol and tryptophan depletion interact to modulate cognition in menopausal women. Neuropsychopharmacology 2006, 31:2489-2497.
14. Kugaya A., Epperson C.N., Zoghbi S., et al. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry 2003, 160:1522-1524.
15. LeBlanc E.S., Neiss M.B., Carello P.E., et al. Hot flashes and estrogen therapy do not influence cognition in early menopausal women. Menopause 2007, 14:191-202.
16. Polo-Kantola P., Erkkola R. Sleep and the menopause. J Br Menopause Soc 2004, 10:145-150.
17. Maki P.M., Drogos L.L., Rubin L.H., et al. Objective hot flashes are negatively related to verbal memory performance in midlife women. Menopause 2008, 15:848-856.
18. Meldrum D.R., Defazio J.D., Erlik Y., et al. Pituitary hormones during the menopausal hot flash. Obstet Gynecol 1984, 64:752-756.
19. Kirschbaum C., Kudielka B.M., Gaab J., et al. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosom Med 1999, 61:154-162.
20. Newcomer J.W., Selke G., Melson A.K., et al. Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psychiatry 1999, 56:527-533.
21. Lupien S.J., Gillin C.J., Hauger R.L. Working memory is more sensitive than declarative memory in humans. Behav Neurosci 1999, 113:420-430.
22. Seeman T.E., McEwen B.S., Singer B.H., et al. Increase in urinary cortisol excretion and memory declines: MacArthur Studies of Successful Aging. J Clin Endocrinol Metab 1997, 82:2458-2465.
23. Greendale G.A., Kritz-Silverstein D., Seeman T., et al. Higher basal cortisol predicts verbal memory loss in postmenopausal women: Rancho Bernardo Study. J Am Geriatr Soc 2000, 48:1655-1658.
24. Lupien S.J., de Leon M., de Santis S., et al. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci 1998, 1:69-73.
25. McEwen B.S., Magarinos A.M. Stress effects on morphology and function of the hippocampus. Ann N Y Acad Sci 1997, 821:271-284.
26. Karlamangla A.S., Singer B.H., Chodosh J., et al. Urinary cortisol excretion as a predictor of incident cognitive impairment. Neurobiol Aging 2005, 26(Suppl 1):80-84.
27. Kirschbaum C., Wust S., Hellhammer D. Consistent sex differences in cortisol responses to psychological stress. Psychosom Med 1992, 54:648-657.
28. Kajantie E., Phillips D.I.W. The effects of sex and hormone status on the physiological response to acute psychosocial stress. Psychoneuroendocrinology 2006, 31:151-178.
29. Symonds C.S., Gallagher P., Thompson J.M., et al. Effects of the menstrual cycle on mood, neurocognitive and neuroendocrine function in healthy premenopausal women. Psychol Med 2004, 34:93-102.
30. Seeman T.E., Singer B., Wilkinson C.W., et al. Gender difference s in age-related changes in HPA axis reactivity. Psychoneuroendocrinology 2001, 26:225-240.
31. Otte C., Hart S., Nevlan T.C., et al. A meta-analysis of cortisol response to challenge in human aging: importance of gender. Psychoneuroendocrinology 2005, 30:80-91.
32. Woods N.F., Mitchell E.S., Smith-DiJulio K. Cortisol levels during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause 2009, 16:708-718.
33. Woods N.F., Carr M.C., Tao E.Y., et al. Increased urinary cortisol levels during the menopausal transition. Menopause 2006, 13:212-221.
34. LaCroix A.Z., Chlebowski R.T., Manson J.E., et al. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA 2011, 305:1305-1314. WHI Investigators.
35. Salpeter S.R., Walsh J.M., Greyber E., et al. Brief report: coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis. J Gen Intern Med 2006, 21:363-366.
36. Sherwin B.B., Henry J.F. Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review. Front Neuroendocrinol 2008, 29:88-113.
37. Maki P.M. Hormone therapy and cognitive function: is there a critical period for benefit?. Neuroscience 2006, 138:1027-1030.
38. Maffucci J.A., Gore A.C. Age-related changes in hormones and their receptors in animal models of female reproductive senescence. Handbook of models for human aging 2006, 533-552. Academic Press and Elsevier, San Diego. M.P. Conn (Ed.).
39. Dumas J.A., Newhouse P.A. The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation. Pharmacol Biochem Behav 2011 Mar 5, [Epub ahead of print].
40. Van Kempen T.A., Milner T.A., Waters E.M. Accelerated ovarian failure: a novel, chemically induced animal model of menopause. Brain Res 2011, 1379:176-187.
41. Acosta J.I., Mayer L.P., Braden B.B., et al. The cognitive effects of conjugated equine estrogens depend on whether menopause etiology is transitional or surgical. Endocrinology 2010, 151:3795-3804.
42. Markowska A.L., Savonenko A.V. Effectiveness of estrogen replacement in restoration of cognitive function after long-term estrogen withdrawal in aging rats. J Neurosci 2002, 22:10985-10995.
43. Savonenko A.V., Markowska A.L. The cognitive effects of ovariectomy and estrogen replacement are modulated by aging. Neuroscience 2003, 119:821-830.
44. Fader A.J., Johnson P.E., Dohanich G.P. Estrogen improves working but not reference memory and prevents amnestic effects of scopolamine of a radial-arm maze. Pharmacol Biochem Behav 1999, 62:711-717.
45. Gibbs R.B. Estrogen replacement enhances acquisition of a spatial memory task and reduces deficits associated with hippocampal muscarinic receptor inhibition. Horm Behav 1999, 36:222-233.
46. Dumas J., Hancur-Bucci C., Naylor M., et al. Estradiol interacts with the cholinergic system to affect verbal memory in postmenopausal women: evidence for the critical period hypothesis. Horm Behav 2008, 53:159-169.
47. Dumas J., Hancur-Bucci C., Naylor M., et al. Estrogen treatment effects on anticholinergic-induced cognitive dysfunction in normal postmenopausal women. Neuropsychopharmacology 2006, 31:2065-2078.
48. Craig M.C., Fletcher P.C., Daly E.M., et al. Reversibility of the effects of acute ovarian hormone suppression on verbal memory and prefrontal function in pre-menopausal women. Psychoneuroendocrinology 2008, 33:1426-1431.
49. Craig M.C., Fletcher P.C., Daly E.M., et al. Gonadotropin hormone releasing hormone agonists alter prefrontal function during verbal encoding in young women. Psychoneuroendocrinology 2007, 32:1116-1127.
50. Craig M.C., Fletcher P.C., Daly E.M., et al. The interactive effect of the cholinergic system and acute ovarian suppression on the brain: an fMRI study. Horm Behav 2009, 55:41-49.
51. Maki P.M., Dennerstein L., Clark M., et al. Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life. Brain Res 2011, 1379:232-243.
52. Erickson K.I., Voss M.W., Prakash R.S., et al. A cross-sectional study of hormone treatment and hippocampal volume in postmenopausal women: evidence for a limited window of opportunity. Neuropsychology 2010, 24:68-76.
53. Brinton R.D. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Ann N Y Acad Sci 2005, 1052:57-74.
54. Resnick S.M., Espeland M.A., Jaramillo S.A., et al. Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study. Neurology 2009, 72:135-142.
55. Espeland M., Rapp S., Shumaker S., et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004, 291:2959-2968.
56. Tierney M.C., Oh P., Moineddin R., et al. A randomized double-blind trial of the effects of hormone therapy on delayed verbal recall in older women. Psychoneuroendocrinology 2009, 34:1065-1074.
57. Fuh J.L., Wang S.J., Lee S.J., et al. A longitudinal study of cognition change during early menopausal transition in a rural community. Maturitas 2006, 53:351-362.
58. Meyer P.M., Powell L.H., Wilson R.S., et al. A population-based longitudinal study of cognitive functioning in the menopausal transition. Neurology 2003, 61:801-806.
59. Greendale G.A., Huang M.H., Wight R.G., et al. Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology 2009, 72:1850-1857.
60. Lamar M., Resnick S.M., Zonderman A.B. Longitudinal changes in verbal memory in older adults: distinguishing the effects of age from repeat testing. Neurology 2003, 60:82-86.
61. Sowers M.F., Crawford S.L., Sternfeld B., et al. SWAN: a multicenter, multiethnic, community-based cohort study of women and the menopausal transition. Menopause biology and pathobiology 2000, 175-188. Academic Press, San Diego. R.A. Lobo, J. Kelsey, R. Marcus (Eds.).
62. Smith A. Symbol digit modalities test 1982, Western Psychological Service, Los Angeles.
63. Albert M., Smith L.A., Scherr P.A., et al. Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci 1991, 57:167-178.
64. Wechsler D. A standardized memory scale for clinical use. J Psychol 1945, 19:87-95.
65. Jonides J., Smith E.E., Marsheutz C., et al. Inhibition in verbal working memory revealed by brain activation. Proc Natl Acad Sci U S A 1998, 95:8410-8413.
66. Maki P.M., Sundermann E. Hormone therapy and cognitive function. Hum Reprod Update 2009, 15:667-681.
67. Barrett-Connor E., Laughlin G.A. Endogenous and exogenous estrogen, cognitive function, and dementia in postmenopausal women: evidence from epidemiologic studies and clinical trials. Semin Reprod Med 2009, 27:275-282.
68. Randolph J.F., Zheng H., Sowers M.R., et al. Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J Clin Endocrinol Metab 2011, 96:746-754.
69. Gold E.B., Colvin A., Avis N., et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: Study of Women's Health Across the Nation. Am J Public Health 2006, 96:1226-1235.
70. Bromberger J.T., Meyer P.M., Kravitz H.M., et al. Psychologic distress and natural menopause: a multiethnic community study. Am J Public Health 2001, 91:1435-1442.
71. Bromberger J.T., Matthews K.A., Schott L.L., et al. Depressive symptoms during the menopausal transition: the Study of Women's Health Across the Nation (SWAN). J Affect Disord 2007, 103:267-272.
72. Kravitz H.M., Zhao X., Bromberger J.T., et al. Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women. Sleep 2008, 31:979-990.
73. Woods N.F., Mitchell E.S. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives. Am J Med 2005, 118(Suppl 12B):14-24.
74. Freeman E.W., Sammel M.D., Lin H., et al. Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol 2007, 110:230-240.
75. Cohen L.S., Soares C.N., Vitonis A.F., et al. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 2006, 63:385-390.
76. Freeman E.W., Sammel M.D., Lin H. Temporal associations of hot flashes and depression in the transition to menopause. Menopause 2009, 16:728-734.
77. Young T., Rabago D., Zgierska A., et al. Objective and subjective sleep quality in premenopausal, perimenopausal, and postmenopausal women in the Wisconsin Sleep Cohort Study. Sleep 2003, 26:667-672.
78. Zakzanis K.K., Leach L., Kaplan E. On the nature and pattern of neurocognitive function in major depressive disorder. Neuropsychiatry Neuropsychol Behav Neurol 1998, 11:111-119.
79. Wetherell J.L., Reynolds C.A., Gatz M., et al. Anxiety, cognitive performance, and cognitive decline in normal aging. J Gerontol B Psychol Sci Soc Sci 2002, 57:246-255.
80. Beaudreau S.A., O'Hara R. Late-life anxiety and cognitive impairment: a review. Am J Geriatr Psychiatry 2008, 16:790-803.
81. Eysenck M.W., Derakshan N., Santos R., et al. Anxiety and cognitive performance: attentional control theory. Emotion 2007, 7:336-353.
82. Matthews K.A., Kuller L.H., Sutton-Tyrrell K., et al. Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women. Stroke 2001, 32:1104-1111.
83. Launer L.J. Demonstrating the case that AD is a vascular disease: epidemiologic evidence. Ageing Res Rev 2002, 1:61-77.
84. Decarli C. Vascular factors in dementia: an overview. J Neurol Sci 2004, 226:19-23.
85. Breteler M.M. Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging 2000, 21:153-160.
86. Stampfer M.J. Cardiovascular disease and Alzheimer's disease: common links. J Intern Med 2006, 260:211-223.
87. Schneider J.A., Arvanitakis Z., Bang W., et al. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 2007, 69:2197-2204.
88. Snowdon D.A., Greiner L.H., Mortimer J.A., et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997, 277:813-817.
89. Esiri M.M., Nagy Z., Smith M.Z., et al. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 1999, 354:919-920.
90. Riekse R.G., Leverenz J.B., McCormick W., et al. Effect of vascular lesions on cognition in Alzheimer's disease: a community-based study. J Am Geriatr Soc 2004, 52:1442-1448.
91. Vermeer S.E., Prins N.D., den Heijer T., et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003, 348:1215-1222.
92. Elias M.F., Sullivan L.M., D'Agostino R.B., et al. Framingham stroke risk profile and lowered cognitive performance. Stroke 2004, 35:404-409.
93. Au R., Massaro J.M., Wolf P.A., et al. Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. Arch Neurol 2006, 63:246-250.
94. de Groot J.C., de Leeuw F.E., Oudkerk M., et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000, 47:145-151.
95. Gunning-Dixon F.M., Raz N. Neuroanatomical correlates of selected executive functions in middle-aged and older adults: a prospective MRI study. Neuropsychologia 2003, 41:1929-1941.
96. Prins N.D., van Dijk E.J., den Heijer T., et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 2005, 128:2034-2041.
97. Tullberg M., Fletcher E., DeCarli C., et al. White matter lesions impair frontal lobe function regardless of their location. Neurology 2004, 63:246-253.
98. Whitmer R.A., Sidney S., Selby J., et al. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 2005, 64:277-281.
99. Skoog I., Lernfelt B., Landahl S., et al. A 15-year longitudinal study of blood pressure and dementia. Lancet 1996, 347:1141-1145.
100. Notkola I.L., Sulkava R., Pekkanen J., et al. Serum total cholesterol, apolipoprotein E4, and Alzheimer's disease. Neuroepidemiology 1998, 17:14-20.
101. Kivipelto M., Helkala E.L., Hanninen T., et al. Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology 2001, 56:1683-1689.
102. Launer L.J., Ross G.W., Petrovitch H., et al. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging 2000, 21:49-55.
103. Whitmer R.A., Gunderson E.P., Quesenberry C.P., et al. Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr Alzheimer Res 2007, 4:103-109.
104. Fitzpatrick A.K., Kuller L.H., Lopez O.L., et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol 2009, 66:336-342.
105. Roberts R.O., Geda Y.E., Knopman D.S., et al. Association of duration and severity of diabetes mellitus with mild cognitive impairment. Arch Neurol 2008, 65:1066-1073.
106. Xu W., Qui C., Gatz M., et al. Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study. Diabetes 2009, 58:71-77.